Breaking Through Barriers with Value-Based Plan Design

January 15, 2025

Finding a Valuable PBM Partner

Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective behaviors and identifying cost-savings opportunities via real-time modeling. Blain’s was also seeking enhanced support for its coronary heart disease (CHD) and diabetes case management program, which could benefit many of its members.

Developing a Focused Strategy

Collaborating with Blain’s to develop a focused strategy for targeted member populations, Navitus proposed the use of value-based plan design programs. Tailored to specific population needs, these programs encourage medical care and improve access to high-touch services by reducing or eliminating financial barriers. Evidence suggests that this promotes adherence, improves member health and can ultimately reduce hospitalization and medical costs.

With these goals in mind, Blain’s implemented CHD and diabetes condition management programs that reduced the copay for generic drugs from $10 to $2 and preferred brand drugs from $25 to $10 for enrolled members.

Infographic titled “At a Glance” with an orange header. It highlights key metrics for Blain’s Farm and Fleet: 2,000 members, reduced copay for generic drugs from $25 to $10, reduced copay for brand drugs from $25 to $10, and increased generic utilization by 9%. Icons include a group of people, a pill bottle with tablets, a downward arrow with a dollar bill, and an upward arrow with a pill bottle.

Increasing Member Adherence

As a result of the lower generic copay, Blain’s saw its generic utilization rate increase to over 9%.

More importantly, adherence rates for members enrolled in Navitus’ condition management program increased significantly, as shown in the table at the right.

Value-based programs are an effective solution for helping members remain adherent to their medications and better manage their disease states, ultimately lowering medical costs for both members and plans.

Getting Started

Are you interested in exploring a truly transparent, pass-through model could lower your plan spend and increase value to your employees? Contact us at [email protected] to learn more.

Bar chart titled “Adherence Rates” comparing overall population to members enrolled in a condition management program for three medication categories. 

For Anti-Hyperlipidemics, adherence is 79% for overall population (gray bar) and 84% for enrolled members (orange bar). 

For Anti-Hypertensives, adherence is 80% overall and 85% enrolled. 

For Oral Anti-Diabetics, adherence is 70% overall and 71% enrolled. 

Legend indicates gray for overall population and orange for enrolled members.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Navigating with a trusted partner

Now Available: 9th Annual Drug Trend Report

Our Drug Trend Report provides a clear view of the trends shaping pharmacy benefits today, along with strategies that are delivering real savings without compromising care.

Related blogs

Navigating Healthcare and Improving Outcomes

Navigating the Key Drivers of Drug Spend and Utilization

Navigating the Key Drivers of Drug Spend and Utilization

Prescription drug spending rose by 11.4% in 2024, reshaping how plan sponsors approach their pharmacy benefit strategy. Costs climbed as existing therapies expanded, new treatments entered the market and coverage decisions shifted pricing dynamics. For…

previous arrow
next arrow